Cargando…

Identification and validation of a prognostic-related mutant gene DNAH5 for hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide and has a poor prognosis. Thus, there is a need for an effective biomarker to improve and predict the prognosis of HCC. METHODS: RNA sequencing data, simple nucleotide variation data, and clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Zebing, Song, Xiaodong, Li, Hang, Cheng, Zongbing, Mo, Zengyi, Yang, Xuewei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630911/ https://www.ncbi.nlm.nih.gov/pubmed/38022557 http://dx.doi.org/10.3389/fimmu.2023.1236995

Ejemplares similares

The association between methylation patterns of DNAH17 and clinicopathological factors in hepatocellular carcinoma
por: Fan, Xiaoxiao, et al.
Publicado: (2018)

Co-occurrence of Moyamoya syndrome and Kartagener syndrome caused by the mutation of DNAH5 and DNAH11: a case report
por: Zhang, Lili, et al.
Publicado: (2020)

Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Xiang, Shixin, et al.
Publicado: (2021)

Novel homozygous mutations of DNAH5 in Kartagener syndrome
por: Cheng, Xian-Dong, et al.
Publicado: (2021)

Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma
por: Zhou, Yangying, et al.
Publicado: (2022)

Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma
por: Chen, Dan, et al.
Publicado: (2023)

A Japanese Case of Primary Ciliary Dyskinesia with DNAH5 Mutations
por: Orimo, Mami, et al.
Publicado: (2019)

Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
por: Ding, Lei, et al.
Publicado: (2022)

Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2021)

CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma
por: Liu, Yanli, et al.
Publicado: (2022)

Whole-exome sequencing identification of novel DNAH5 mutations in a young patient with primary ciliary dyskinesia
por: Kano, Gen, et al.
Publicado: (2016)

DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease
por: Lee, Jin Hwa, et al.
Publicado: (2014)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Yan, Zongcai, et al.
Publicado: (2021)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Sun, Qi, et al.
Publicado: (2021)

A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Identification of DNAH6 mutations in infertile men with multiple morphological abnormalities of the sperm flagella
por: Tu, Chaofeng, et al.
Publicado: (2019)

Identification of DNAH17 Variants in Han-Chinese Patients With Left–Right Asymmetry Disorders
por: Yu, Xuehui, et al.
Publicado: (2022)

Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma
por: He, Qifan, et al.
Publicado: (2022)

Multiomics Analysis of a DNAH5-Mutated PCD Organoid Model Revealed the Key Role of the TGF-β/BMP and Notch Pathways in Epithelial Differentiation and the Immune Response in DNAH5-Mutated Patients
por: Yang, Wenhao, et al.
Publicado: (2022)

Corrigendum: A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma
por: Song, ZeBing, et al.
Publicado: (2021)

A novel frameshift mutation in DNAH6 associated with male infertility and asthenoteratozoospermia
por: Huang, Fei, et al.
Publicado: (2023)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Variation in DNAH1 may contribute to primary ciliary dyskinesia
por: Imtiaz, Faiqa, et al.
Publicado: (2015)

Novel variants in DNAH9 lead to nonsyndromic severe asthenozoospermia
por: Tang, Dongdong, et al.
Publicado: (2021)

Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma
por: Wang, Jiru, et al.
Publicado: (2019)

Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
por: Xia, Xinxin, et al.
Publicado: (2021)

Genome-wide association study in minority children with asthma implicates DNAH5 in bronchodilator responsiveness
por: Joo, Jaehyun, et al.
Publicado: (2022)

Dnah9 mutant mice and organoid models recapitulate the clinical features of patients with PCD and provide an excellent platform for drug screening
por: Zheng, Rui, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma
por: Chen, Shujia, et al.
Publicado: (2022)

Novel compound heterozygous mutations of DNAH5 identified in a pediatric patient with Kartagener syndrome: case report and literature review
por: Wang, Lina, et al.
Publicado: (2021)

Identification of compound heterozygous DNAH11 variants in a Han‐Chinese family with primary ciliary dyskinesia
por: Xiong, Ying, et al.
Publicado: (2021)

Sleep Deprivation Disturbs Immune Surveillance and Promotes the Progression of Hepatocellular Carcinoma
por: Huang, Jing, et al.
Publicado: (2021)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2021)

Identification of serum glycobiomarkers for Hepatocellular Carcinoma using lectin microarrays
por: Zhang, Yue, et al.
Publicado: (2022)

Association of DNAH11 gene polymorphisms with asthenozoospermia in Northeast Chinese patients
por: Zhu, Dongliang, et al.
Publicado: (2019)

A DNAH17 missense variant causes flagella destabilization and asthenozoospermia
por: Zhang, Beibei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ct900tbgd4og3vid1964780b5n